A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

575

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

November 21, 2023

Conditions
Dry EyeDry Eye Syndromes
Interventions
DRUG

Vehicle Ophthalmic Solution

Ophthalmic Solution

DRUG

PL9643 Ophthalmic Solution

Ophthalmic Solution

Trial Locations (18)

16507

Erie Retina Research, LLC, Erie

28150

Core, Inc, Shelby

28227

Mint Hill, Mint Hill

37072

Advancing Vision Research, Goodlettsville

37167

Advancing Vision Research, Smyrna

38119

Total Eye Care, PA, Memphis

40206

Butchertown Clinical Trials, Louisville

40517

Kentucky Eye Institute, Lexington

46240

Michael Washburn Center for Ophthalmic Research, LLC, Indianapolis

47203

Pankratz Eye Institute, Columbus

58103

Bergstrom Eye research, LLC, Fargo

75243

Axis Clinical, Dallas

78750

Austin Clinical Research, Austin

89052

Center for Sight, Las Vegas

90505

East West Eye Institute, Torrance

91204

Global Research Management, Glendale

92663

Eye Research Foundation, Newport Beach

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

Palatin Technologies, Inc

INDUSTRY